MarketCap
Facebook
X
TelegramAnnual report 2025
added 02-19-2026
Tandem Diabetes Care Total Current Liabilities 2011-2026 | TNDM
Annual Total Current Liabilities Tandem Diabetes Care
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 243 M | 247 M | 195 M | 165 M | 132 M | 104 M | 99.4 M | 66.3 M | 36.1 M | 31.5 M | 26.5 M | 18.1 M | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 247 M | 18.1 M | 114 M |
Total Current Liabilities of other stocks in the Medical devices industry
| Issuer | Total Current Liabilities | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
GenMark Diagnostics, Inc.
GNMK
|
44.1 M | - | - | $ 1.77 B |  USA |
 |
Apollo Endosurgery
APEN
|
39.5 M | - | - | $ 475 M | USA |
 |
Acutus Medical
AFIB
|
18.9 M | - | -26.83 % | $ 2.62 M | USA |
 |
Avinger
AVGR
|
19.3 M | - | -20.74 % | $ 369 K | USA |
 |
Axonics Modulation Technologies
AXNX
|
65.2 M | - | - | $ 3.31 B | USA |
 |
Aziyo Biologics
AZYO
|
25.1 M | - | 1.37 % | $ 20.5 M | USA |
 |
Allied Healthcare Products
AHPI
|
5.98 M | - | 3.58 % | $ 2.21 M | USA |
 |
Obalon Therapeutics, Inc.
OBLN
|
5.05 M | - | -5.86 % | $ 30.6 M | USA |
 |
BioSig Technologies
BSGM
|
42.8 M | - | 37.08 % | $ 85.7 M | USA |
 |
Cardiovascular Systems
CSII
|
40 M | - | 0.15 % | $ 844 M | USA |
 |
Cutera
CUTR
|
87.7 M | - | -10.19 % | $ 1.99 M | USA |
 |
CryoLife, Inc.
CRY
|
60.5 M | - | -4.14 % | $ 702 M | USA |
 |
Dynatronics Corporation
DYNT
|
8.24 M | - | 14.99 % | $ 929 K | USA |
 |
Eargo
EAR
|
25.3 M | - | - | $ 10.2 M | USA |
 |
Abbott Laboratories
ABT
|
16.5 B | $ 102.58 | -0.28 % | $ 179 B | USA |
 |
Soliton, Inc.
SOLY
|
2.82 M | - | -1.42 % | $ 435 M | USA |
 |
Conformis
CFMS
|
14.1 M | - | - | $ 16.4 M | USA |
 |
Hancock Jaffe Laboratories, Inc.
HJLI
|
3.19 K | - | -1.98 % | $ 98.3 M | USA |
 |
Itamar Medical Ltd.
ITMR
|
18 M | - | 0.03 % | $ 1.58 B |  Israel |
 |
Misonix, Inc.
MSON
|
17.3 M | - | - | $ 462 M | USA |
 |
Second Sight Medical Products
EYES
|
6.6 M | - | -0.97 % | $ 54.4 M | USA |
 |
Intersect ENT, Inc.
XENT
|
44.2 M | - | - | $ 955 M | USA |
 |
BIOLASE
BIOL
|
19.7 M | - | -13.19 % | $ 166 K | USA |
 |
AdaptHealth Corp.
AHCO
|
712 M | $ 12.17 | 1.16 % | $ 1.64 B | USA |
 |
Invacare Corporation
IVC
|
220 M | - | - | $ 24.7 M | USA |
 |
Align Technology
ALGN
|
2.04 B | $ 172.16 | 0.91 % | $ 12.9 B | USA |
 |
Apyx Medical Corporation
APYX
|
11.7 M | $ 3.88 | 5.43 % | $ 159 M | USA |
 |
Alphatec Holdings
ATEC
|
219 M | $ 10.93 | 0.92 % | $ 1.64 B | USA |
 |
AxoGen
AXGN
|
23.6 M | $ 33.66 | -2.26 % | $ 1.55 B | USA |
 |
Butterfly Network
BFLY
|
48.2 M | $ 4.1 | -0.36 % | $ 868 M | USA |
 |
Bruker Corporation
BRKR
|
1.28 B | $ 36.75 | -0.03 % | $ 5.48 K | USA |
 |
Boston Scientific Corporation
BSX
|
5.44 B | $ 63.21 | 0.62 % | $ 93.6 B | USA |
 |
ClearPoint Neuro
CLPT
|
10.8 M | $ 9.53 | 1.71 % | $ 270 M | USA |
 |
CONMED Corporation
CNMD
|
315 M | $ 34.78 | -0.03 % | $ 1.08 B | USA |
 |
Cytosorbents Corporation
CTSO
|
9.71 M | $ 0.6 | 2.92 % | $ 37.3 M | USA |
 |
Delcath Systems
DCTH
|
11 M | $ 9.72 | 0.88 % | $ 348 M | USA |
 |
EDAP TMS S.A.
EDAP
|
27.6 M | $ 3.56 | 5.0 % | $ 133 M |  France |
 |
Electromed
ELMD
|
10.5 M | $ 23.59 | 1.29 % | $ 199 M | USA |
 |
Edwards Lifesciences Corporation
EW
|
1.81 B | $ 81.57 | 0.64 % | $ 47.7 B | USA |
 |
FONAR Corporation
FONR
|
16.7 M | $ 18.56 | -0.16 % | $ 122 M | USA |
 |
NanoVibronix
NAOV
|
2.72 M | - | - | $ 1.08 M | USA |
 |
Globus Medical
GMED
|
498 M | $ 87.65 | -0.31 % | $ 11.9 B | USA |
 |
Helius Medical Technologies
HSDT
|
1.88 M | $ 1.97 | 5.65 % | $ 1.2 M | USA |
 |
Integra LifeSciences Holdings Corporation
IART
|
922 M | $ 9.4 | -1.36 % | $ 724 M | USA |
 |
Inogen
INGN
|
63.5 M | $ 6.46 | 4.03 % | $ 172 M | USA |
 |
Inspire Medical Systems
INSP
|
96.1 M | $ 56.86 | 3.4 % | $ 1.67 B | USA |
 |
IRIDEX Corporation
IRIX
|
13.2 M | $ 1.01 | 3.09 % | $ 17.1 M | USA |